Сombined radiotherapy for cervical cancer with the use of polyradiosensitization with cisplatin and gemcitabine - immediate trial results of Azerbaijan national center of oncology
- Authors: Aliyev JA1, Isayev IH1, Akbarov KS1, Guliyev EH1, Aliyeva NR1, Aliyeva NS1
-
Affiliations:
- National Center of Oncology
- Issue: Vol 98, No 6 (2017)
- Pages: 884-889
- Section: Theoretical and clinical medicine
- Submitted: 04.12.2017
- Published: 15.12.2017
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/7233
- DOI: https://doi.org/10.17750/KMJ2017-884
- ID: 7233
Cite item
Full Text
Abstract
About the authors
J A Aliyev
National Center of Oncology
Author for correspondence.
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
I H Isayev
National Center of Oncology
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
K S Akbarov
National Center of Oncology
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
E H Guliyev
National Center of Oncology
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
N R Aliyeva
National Center of Oncology
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
N S Aliyeva
National Center of Oncology
Email: akperovkamal@yahoo.com
Baku, Azerbaijan
References
- International Agency for Research on Cancer / World Health Organization. Latest world cancer statistics. Press release №223, 12 December 2013. https://www.iarc.fr/en (access date: 13.04.2017).
- GLOBOCAN 2012: estimated cancer incidence, mortality and prevalenceworldwide in 2012. http://globocan.iarc.fr. (access date: 13.04.2017).
- Алиев Д.А., Марданлы Ф.А., Гулиев Ф.А. и др. Эпидемиологические аспекты злокачественных новообразований в Азербайджанской Республике за 2008-2013 гг. Азербайджанский ж. онкол. и гематол. 2014; (2): 6-12.
- Исаев И.Г., Акперов К.С. Перспективы применения таргетных препаратов в лечении рака шейки матки. Азербайджанский ж. онкол. и гематол. 2015; (1): 25-30.
- Minig L., Patrono M., Romero N. et al. Different strategies of treatment for uterine cervical carcinoma stage IB2-IIIB. World J. Clin. Oncol. 2014; 5 (2): 86-92. doi: 10.5306/wjco.v5.i2.86.
- Viswanathan A., Beriwal S., Santos J. et al. The American Brachytherapy Society Treatment Recommendations for locally advanced carcinoma of the cervix. Part II: High Dose-Rate Brachytherapy. Brachytherapy. 2012; 14 (1): 47-52. doi: 10.1016/j.brachy.2011.07.002.
- Hanna T., Delaney G., Barton M. The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates. Radiotherap. Oncol. 2016; 120 (3): 370-377. doi: 10.1016/j.radonc.2016.04.008.
- Sturdza A., Pötter R., Fokdal L. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiotherap. Oncol. 2016; 120 (3): 428-433. doi: 10.1016/j.radonc.2016.03.011.
- Шакирова Э.Ж., Муллагалиева А.М., Хасанов Р.Ш., Сухорукова Л.К. Меcтно-распространённый рак шейки матки: проблемы диагностики и лечения. Казанский мед. ж. 2007; 88 (6): 627-630. .
- Панов А.В., Бурмистров М.В., Рагинов И.С. и др. Опыт использования полирадиомодификации с применением озон-кислородной смеси в комплексном лечении плоскоклеточного рака шейки матки. Казанский мед. ж. 2012; 93 (6): 879-883. .
- Mountzios G., Soultati A., Pectasides D. et al. Novel approaches for concurrent irradiation inlocally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents. Obstet. Gynecol. Intern. 2013; 2013: 1-8. doi: 10.1155/2013/536765.
- Duenas-Gonzalez A., Zarba J., Patel F. et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J. Clin. Oncol. 2011; 29 (13): 1678-1685. doi: 10.1200/JCO.2009.25.9663.
- Yahya S., Bhatt L., King M. et al. Survival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding. Anticancer Res. 2015; 35 (10): 5567-5574. PMID: 26408727.
- Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 2000; 92: 205-216. doi: 10.1093/jnci/92.3.205.
- Cancer therapy evaluation program, Common Terminology Criteria for Adverse Events v3.0- CTCAE V3.0, DCTD, NCI, NIH, DHHS. http://ctep.cancer.gov (access date: 16.04.2017).